ALZN - Biji pasar Alzamend

Alzamend Neuro, Inc. (ALZN) research centers are developing therapies for psychiatric disorders and Alzheimer's disease, leveraging proprietary lithium-based developments. Capital management efficiency is ensured by outsourcing clinical trials to international third-party contractors. The business model is based on a closed patent loop for lithium delivery, and the market capitalization stands at 0.01. The company's price chart clearly illustrates the dynamics of this biotechnology sector.

ALZN Alzamend Neuro Inc.: Kapitalisasi pasar ing interval 04.07.2022 - 22.10.2026

ALZN (alzamend.com): rincian analitis lan laporan miturut indikator

Ringkesan indikator lan parameter pambiji Alzamend Neuro, Inc. (ALZN):

Bagan rega Alzamend Neuro|ALZN - Bagan rega target|Biji pasar Alzamend Neuro

Analisis fundamental perusahaan:ALZN (Alzamend)

Sampel barang Alzamend Neuro Inc.

Alzamend Neuro, Inc. (ALZN) leverages a unique lithium ion delivery technology that provides the company with potential pricing power within the Alzheimer's therapy market. The trend in the company's aggregate market valuation reflects investor expectations regarding this monopoly power. This figure is calculated as the product of the current share price and the total number of outstanding securities. This metric measures the current value of the entire business through the lens of market demand. Steady growth in market capitalization confirms fundamental confidence in the drug's commercialization.

Pesaing wigati

Nilai pasar Biogen BIIB|Neurocrine - Nilai pasar|RGC: Biji pasar|Biji pasar AXSM|ACADIA Pharmaceuticals (ACAD) - Nilai pasar|Kapitalisasi pasar XENE|Nilai pasar Viking Therapeutics, Inc.|Kapitalisasi pasar SUPN (Supernus Pharmaceuticals, Inc.)|Kapitalisasi pasar CPRX|DNLI - Nilai pasar|Harmony Biosciences - Biji pasar|Kapitalisasi pasar biohavenpharma.com BHVN|AMLX - Nilai pasar|Nilai pasar TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Nilai pasar|Nilai pasar Anavex Life Sciences Corp (AVXL)|CBLL (CeriBell, Inc.) - Kapitalisasi pasar|Kapitalisasi pasar Prothena Corp|Nilai pasar Alector, Inc. (ALEC)|Nilai pasar ANNX (Annexon Biosciences)|Omeros - Biji pasar|NGNE (Neurogene Therapeutics) - Biji pasar|AC Immune - Kapitalisasi pasar|VYGR - Kapitalisasi pasar|Neumora Therapeutics, Inc. (NMRA) - Nilai pasar|Biji pasar Scilex Holding|TVGN (Tevogen Bio Holdings, Inc.) - Kapitalisasi pasar|Nilai pasar Alpha Cognition Corp ACOG|Nilai pasar Cognition Therapeutics, Inc. (CGTX)|inhibikase.com - Kapitalisasi pasar|Kapitalisasi pasar SAVA (Cassava Sciences)|ASRT: Kapitalisasi pasar|COYA: Biji pasar|Nilai pasar VTGN (Vistagen Therapeutics)|ovidrx.com (OVID) - Nilai pasar|Kapitalisasi pasar ABOS|CRVO (CervoMed) - Kapitalisasi pasar|Nilai pasar Alterity Therapeutics Ltd ATHE|Biji pasar CLNN (Clene Inc.)|Kapitalisasi pasar pepgen.com (PEPG)|Nilai pasar Jupiter Neurosciences JUNS|Nilai pasar RLMD|ANVS - Nilai pasar|Nilai pasar Grace Therapeutics, Inc.|AIFF (Firefly Neuroscience Inc) - Biji pasar|Klotho Neurosciences - Nilai pasar|NRSN (NeuroSense Therapeutics Ltd) - Kapitalisasi pasar|revivapharma.com (RVPH) - Kapitalisasi pasar|Nilai pasar MetaVia Inc (MTVA)|NeurAxis Inc. - Kapitalisasi pasar|Kapitalisasi pasar HSDT (Helius Medical Technologies)|PASG - Biji pasar|NEUP: Biji pasar|Kapitalisasi pasar minervaneurosciences.com NERV|ATHA: Kapitalisasi pasar|Addex Therapeutics Ltd. (ADXN) - Kapitalisasi pasar|Nilai pasar Cyclerion Therapeutics Inc.|Nilai pasar PTIX|Biji pasar KTTA (Pasithea Therapeutics)|CRGT: Biji pasar|Nilai pasar Avenue Therapeutics, Inc. ATXI|BCLI: Kapitalisasi pasar|CARA - Nilai pasar|CHRO (Chromocell) - Kapitalisasi pasar|ELYM: Kapitalisasi pasar|Nilai pasar Intra-Cellular Therapies, Inc. (ITCI)|Biji pasar LBPH|Kapitalisasi pasar Marinus Pharmaceuticals Inc|Nilai pasar NKGen (NKGN)|NRBO (NeuroBo Pharma) - Nilai pasar|Nilai pasar Sage Therapeutics, Inc. SAGE|synaptogen.com (SNPX) - Nilai pasar|Trevena - Kapitalisasi pasar|VIGL - Kapitalisasi pasar|Anew Medical, Inc. (WENA) - Nilai pasar|CERE (Cerevel Corp) - Nilai pasar